Intravenous magnesium for cardiac arrhythmias: Jack of all trades

Magnesium Research

Volumn 21, Issue 1, 2008, Pages 65-68

  Ho, Kwok Ming ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Antiarrhythmics; Atrial fibrillation; Rhythm control

Indexed keywords

MAGNESIUM;

ARTICLE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION;

ARRHYTHMIAS, CARDIAC; ATRIAL FIBRILLATION; HUMANS; INJECTIONS, INTRAVENOUS; MAGNESIUM;

EID: 42549146629     PISSN: 09531424     EISSN: None     Source Type: Journal    
DOI: 10.1684/mrh.2008.0130     Document Type: Article

References (39)

1. Crippa G, Sverzellati E, Giorgi-Pierfranceschi M, Carrara GC. Magnesium and cardiovascular drugs: interactions and therapeutic role. Ann Ital Med Int 1999; 14: 40-5.
2. Aupetit JF, Freysz M, Faucon G, Loufoua-Moundanga J, Coquelin H, Timour Q. Magnesium-a profibrillatory or antifibrillatory drug depending on plasma concentration, heart rate and myocardial perfusion. Acta Anaesthesiol Scand 1997; 41: 516-23.
3. Evans SJ, Levi AJ, Jones JV. Low magnesium enhances the pro-arrhythmic effect of low potassium in the hypertrophied rat heart but not in the normal rat heart. J Hypertens 1996; 14: 635-44.
4. Haigney MC, Berger R, Schulman S, Gerstenblith G, Tunin C, Silver B, Silverman HS, Tomaselli G, Calkins H. Tissue magnesium levels and the arrhythmic substrate in humans. J Cardiovasc Electrophysiol 1997; 8: 980-6.
5. Durlach J, Guiet-Bara A, Pagès N, Bac P, Bara M. Magnesium chloride or magnesium sulfate: a genuine question. Magnes Res 2005; 18: 187-92.
6. Wu JY, Lipsius SL. Effects of extracellular Mg2+ on T- and L-type Ca2+ currents in single atrial myocytes. Am J Physiol 1990; 259: 1842-50.
7. Fawcett WJ, Haxby EJ, Male DA. Magnesium: physiology and pharmacology. Br J Anaesth 1999; 83: 302-20.
8. Ingemansson MP, Smideberg B, Olsson SB. Intravenous MgSO4 alone and in combination with glucose, insulin and potassium (GIK) prolong the atrial cycle length in chronic atrial fibrillation. Europace 2000; 2: 106-14.
9. Iseri LT, Allen BJ, Ginkel ML, Brodsky MA. Ionic biology and ionic medicine in cardiac arrhythmias with particular reference to magnesium. Am Heart J 1992; 123: 1404-9.
10. DiCarlo Jr. LA, Morady F, de Buitleir M, Krol RB, Schurig L, Annesley TM. Effects of magnesium sulfate on cardiac conduction and refractoriness in humans. J Am Coll Cardiol 1986; 7: 1356-62.
11. Rasmussen HS, Larsen OG, Meier K, Larsen J. Hemodynamic effects of intravenously administered magnesium on patients with ischemic heart disease. Clin Cardiol 1988; 11: 824-8.
12. Christiansen EH, Frost L, Andreasen F, Mortensen P, Thomsen PE, Pedersen AK. Dose-related cardiac electrophysiological effects of intravenous magnesium. A double-blind placebo-controlled dose-response study in patients with paroxysmal supraventricular tachycardia. Europace 2000; 2: 320-6.
13. Vision S, Belhassen B, Sheps D, Laniado S. Clinical and electrophysiologic effects of magnesium sulfate on paroxysmal supraventricular tachycardia and comparison with adenosine triphosphate. Am J Cardiol 1992; 70: 879-85.
14. Sideris AM, Galiatsu E, Filippatos GS, Kappos K, Anthopoulos LP. Effects of magnesium and potassium on Wolff-Parkinson-White syndrome. J Electrocardiol 1996; 29: 11-5.
15. Stiles MK, Sanders P, Disney P, Brooks A, John B, Lau DH, Shashidhar, Wilson L, Mackenzie L, Young GD. Differential effects of intravenous magnesium on atrioventricular node conduction in supraventricular tachycardia. Am J Cardiol 2007; 100: 1249-53.
16. Satoh Y, Sugiyama A, Tamura K, Hashimoto K. Effect of magnesium sulfate on the haloperidol-induced QT prolongation assessed in the canine in vivo model under the monitoring of monophasic action potential. Jpn Circ J 2000; 64: 445-51.
17. Chinushi M, Sugiura H, Komura S, Hirono T, Izumi D, Tagawa M, Furushima H, Aizawa Y. Effects of intravenous magnesium in a prolonged QT interval model of polymorphic ventricular tachycardia focus on transmural ventricular repolarization. Pacing Clin Electro-physiol 2005; 28: 844-50.
18. Chinushi M, Izumi D, Komura S, Ahara S, Satoh A, Furushima H, Washizuka T, Aizawa Y. Role of autonomic nervous activity in the antiarrhythmic effects of magnesium sulfate in a canine model of polymorphic ventricular tachyarrhythmia associated with prolonged QT interval. J Cardiovasc Pharmacol 2006; 48: 121-7.
19. Farouque HM, Sanders P, Young GD. Intravenous magnesium sulfate for acute termination of sustained mono-morphic ventricular tachycardia associated with coronary artery disease. Am J Cardiol 2000; 86: 1270-2.
20. Miller S, Crystal E, Garfinkle M, Lau C, Lashevsky I, Connolly SJ. Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis. Heart 2005; 91: 618-23.
21. Sedrakyan A, Treasure T, Browne J, Krumholz H, Sharp-in C, van der Meulen J. Pharmacologic prophylaxis for postoperative atrial tachyarrhythmia in general thoracic surgery: evidence from randomized clinical trials. J Thorac Cardiovasc Surg 2005; 129: 997-1005.
22. Ho KM, Sheridan DJ, Paterson T. Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis. Heart 2007; 93: 1433-40.
23. Merrill JJ, DeWeese G, Wharton JM. Magnesium reversal of digoxin-facilitated ventricular rate during atrial fibrillation in the Wolff-Parkinson-White syndrome. Am J Med 1994; 97: 25-8.
24. Kalus JS, Spencer AP, Tsikouris JP, Chung JO, Kenyon KW, Ziska M, Kluger J, White CM. Impact of prophylactic i.v. magnesium on the efficacy of ibutilide for conversion of atrial fibrillation or flutter. Am J Health Syst Pharm 2003; 60: 2308-12.
25. Tercius AJ, Kluger J, Coleman CI, White CM. Intravenous magnesium sulfate enhances the ability of intravenous ibutilide to successfully convert atrial fibrillation or flutter. Pacing Clin Electrophysiol 2007; 30: 1331-5.
26. McCord JK, Borzak S, Davis T, Gheorghiade M. Usefulness of intravenous magnesium for multifocal atrialtachycardia in patients with chronic obstructive pulmonary disease. Am J Cardiol 1998; 81: 91-3.
27. LeDuc TJ, Carr JD. Magnesium sulfate for conversion of supraventricular tachycardia refractory to intravenous adenosine. Ann Emerg Med 1996; 27: 375-8.
28. Wesley Jr. RC, Haines DE, Lerman BB, DiMarco JP, Crampton RS. Effect of intravenous magnesium sulfate on supraventricular tachycardia. Am J Cardiol 1989; 63: 1129-31.
29. England MR, Gordon G, Salem M, Chernow B. Magnesium administration and dysrhythmias after cardiac surgery. A placebo-controlled, double-blind, randomized trial. JAMA 1992; 268: 2395-402.
30. Parikka H, Toivonen L, Verkkala K, Järvinen A, Nieminen MS. Ventricular Arrhythmia Suppression by Magnesium Treatment after Coronary Artery Bypass Surgery. Int J Angiol 1999; 8: 165-70.
31. Ceremuzyński L, Gebalska J, Wolk R, Makowska E. Hypomagnesemia in heart failure with ventricular arrhythmias. Beneficial effects of magnesium supplementation. J Intern Med 2000; 247: 78-86.
32. Kinlay S, Buckley NA. Magnesium sulfate in the treatment of ventricular arrhythmias due to digoxin toxicity. J Toxicol Clin Toxicol 1995; 33: 55-9.
33. Nakata K, Moriwaki R, Yamaguchi A, Takenouchi S, Mato T, Tsutsumi H. Case in which magnesium sulfate effectively treated ventricular tachycardia due to overdose of pilsicainide hydrochloride. Chudoku Kenkyu 2006; 19: 49-53.
34. Gupta A, Lawrence AT, Krishnan K, Kavinsky CJ, Trohman RG. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am Heart J 2007; 153: 891-9.
35. Winters SL, Sachs RG, Curwin JH. Nonsustained polymorphous ventricular tachycardia during amiodarone therapy for atrial fibrillation complicating cardiomyopathy. Management with intravenous magnesium sulfate. Chest 1997; 111: 1454-7.
36. Sarisoy O, Babaoglu K, Tugay S, Barn E, Gokalp AS. Efficacy of magnesium sulfate for treatment of ventricular tachycardia in amitriptyline intoxication. Pediatr Emerg Care 2007; 23: 646-8.
37. Knudsen K, Abrahamsson J. Magnesium sulphate in the treatment of ventricular fibrillation in amitriptyline poisoning. Eur Heart J1997; 18: 881-2.
38. AUegra J, Lavery R, Cody R, Birnbaum G, Brennan J, HartmanA, Horowitz M, NashedA, YablonskiM. Magnesium sulfate in the treatment of refractory ventricular fibrillation in the prehospital setting. Resuscitation 2001; 49: 245-9.
39. Hassan TB, Jagger C, Barnett DB. A randomised trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation. Emerg Med J'2002; 19: 57-62.